Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px

Document › Details

Oryzon Genomics S.A.. (3/31/17). "Press Release: Oryzon Raises €18 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA, et al.]". Barcelona.

	Organisation	Oryzon Genomics S.A. (Madrid Stock Exchange: ORY)
	Group	Oryzon Genomics (Group)
	Organisation 2	Guggenheim Securities, LLC
	Group	Guggenheim (Group)
	Product	biopharmaceutical
	Product 2	investment banking
	Index term	Oryzon Genomics–SEVERAL: investment, 201703 private placement €18.2m w 5.7m news common shares at €3.2/share
	Person	Buesa, Carlos (Oryzon Genomics SA 201404 CEO + Co-Founder)

Original document
accessed by [iito] on 2017-04-11

Record changed: 2023-06-05

Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x200px

More documents for Oryzon Genomics (Group)

[1] Oryzon Genomics S.A.. (10/26/18). "Press Release: Oryzon Raises EUR 13 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA or any other jurisdiction where unlawful]". Madrid & Cambridge, MA....
[2] Oryzon Genomics S.A.. (10/22/18). "Press Release: Oryzon to Present at Upcoming International Conferences". Madrid & Cambridge, MA....
[3] Oryzon Genomics S.A.. (5/14/18). "Press Release: Oryzon Announces First Patients In ETHERAL – a Phase IIa Clinical Trial in Alzheimer’s Disease with ORY-2001". Madrid & Cambridge, MA....
[4] Oryzon Genomics S.A.. (10/3/17). "Press Release: Significant Fact [Company Moves Registered Address from Barcelona to Madrid]". Madrid....
[5] Oryzon Genomics S.A.. (7/20/17). "Press Release: Oryzon to Regain Rights to ORY-1001 (RG6016)". Barcelona & Cambridge, MA....
[6] Oryzon Genomics S.A.. (5/31/17). "Press Release: Oryzon Genomics to Participate in a Panel at the JMP Securities Life Sciences Conference and Present at the Jefferies 2017 Global Health Conference". Barcelona & Cambridge, MA....
[7] Oryzon Genomics S.A.. (5/16/17). "Press Release: Oryzon Announces Appointment of New Chief Medical Officer and Expansion of Its Medical Department". Barcelona & Cambridge, MA....
[8] Oryzon Genomics S.A.. (2/27/17). "Press Release: Oryzon Presented New Preclinical Data of ORY-2001 Therapeutic Activity in Multiple Sclerosis at ACTRIMS-2017". Barcelona & Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]